The Calmer Co. inks $2m-a-year kava supply deal with U.S. beverage group

Fiji Kava Limited ( (AU:CCO) ) has shared an update.

The Calmer Co. International Limited has signed a 24‑month master supply agreement with a leading U.S.-based kava functional beverage company for premium CO₂-extracted kava ingredients. The non-exclusive deal, which uses a quarterly supply framework aligned to the customer’s production planning, preserves the Australian group’s ability to supply other global partners.

The contract includes a minimum revenue commitment of about AU$1.58 million over two years, with expected annual revenue of roughly $2 million based on the customer’s inventory forecasts, and pricing set in U.S. dollars with review mechanisms tied to raw material costs. Management said the agreement is a key milestone in its B2B ingredient strategy, providing stronger revenue visibility and reinforcing its position as a preferred kava supplier as demand for kava-based functional beverages grows in the U.S. market.

The most recent analyst rating on (AU:CCO) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Fiji Kava Limited stock, see the AU:CCO Stock Forecast page.

More about Fiji Kava Limited

The Calmer Co. International Limited is an ASX-listed consumer packaged goods company that specialises in kava and other natural products aimed at relaxation, sleep support and providing healthier alternatives to alcohol. The business focuses on supplying premium kava ingredients and finished products to beverage and wellness brands, with an increasing emphasis on higher-margin B2B ingredient sales in international markets such as the U.S.

Technical Sentiment Signal: Sell

Current Market Cap: A$12.23M

See more data about CCO stock on TipRanks’ Stock Analysis page.